The role of positron emission tomography in the management of recurrent colorectal cancer: A review

Diseases of the Colon and Rectum

Volumn 50, Issue 1, 2007, Pages 102-114

  Watson, A J M ^a   Lolohea, S ^b   Robertson, G M ^b   Frizelle, F A ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Positron emission tomography; Recurrent colorectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY TC 99M; FLUORODEOXYGLUCOSE F 18; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B.72.3 IN 111; MONOCLONAL ANTIBODY BW431 26 TC 99M; UNCLASSIFIED DRUG;

CANCER STAGING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG METASTASIS; MEDICAL DECISION MAKING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RECURRENT CANCER; REVIEW; SCAR; SENSITIVITY AND SPECIFICITY;

EID: 33846456968     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-006-0735-7     Document Type: Review

References (99)

1. HJ Wanebo DL Gaker R Whitehill RF Morgan WC Constable 1987 Pelvic recurrence of rectal cancer. Options for curative resections Ann Surg 205 482 495
2. K Suzuki RR Dozoiz RM Devine 1996 Curative reoperations for locally recurrent rectal cancer Dis Colon Rectum 39 730 736
3. JC Salo PB Paty J Guillem BD Minsky LB Harrison AM Cohen 1999 Surgical salvage of recurrent rectal carcinoma after curative resection: a 10 year experience Ann Surg Oncol 6 171 177
4. G Steele Jr R Bleday RJ Mayer A Lindblad N Petrelli D Weaver 1991 A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584 J Clin Oncol 9 1105 1112
5. AC Wei PD Greig B Taylor 2006 Survival after hepatic resection for colorectal metastases: a 10-year experience Ann Surg Oncol 13 668 676
6. RC Viney MJ Boyer MT King 2004 Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer J Clin Oncol 22 2357 2362
7. AF Verhagen GP Bootsma VC Tjan-Heijnen 2004 FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer 44 175 181
8. H Nomori K Watanabe T Ohtsuka T Naruke K Suemasu K Uno 2004 Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images Lung Cancer 4 19 27
9. 18F]FDG imaging of head and neck tumors: comparison of hybrid PET and morphological methods Eur J Nucl Med Mol Imaging 30 995 1003
10. W Siggelkow M Zimny A Faridi K Petzold U Buell W Rath 2003 The value of positron emission tomography in the follow-up for breast cancer. Anticancer Res 2003;23(2C):1859-67. Erratum in Anticancer Res 23 5370
11. D Fuster S Chiang G Johnson LM Schuchter H Zhuang A Alavi 2004 Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 45 1323 1327
12. O Warburg F Wind E Neglers 1980 On the metabolism of tumors in the body O Warburg Metabolism of tumors Constable London 254 270
13. ME Juweid BD Cheson 2006 Positron-emission tomography and assessment of cancer therapy N Engl J Med 354 496 507
14. JS Flier MM Mueckler P Usher HF Lodish 1987 Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes Science 235 1492 1495
15. P Som HL Atkins D Bandoypadhay 1980 Afluorinated glucose analog 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection J Nucl Med 21 670 675
16. G Di Chiro E Oldfield D Bairamian 1985 In-vivo glucose utilisation of tumors of the brain stem and spinal cord T Greitz DH Ingvar Positron emission tomography Raven New York 351 361
17. S Galandiuk HS Wieand CG Moertel 1992 Patterns of recurrence after curative resection of carcinoma of the colon and rectum Surg Gynecol Obstet 174 27 32
18. AW Cass RR Million WW Pfaff 1976 Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum Cancer 37 2861 2865
19. RM Olson NP Perencevich AW Malcolm JT Chaffey RE Wilson 1980 Pattern of recurrence following curative resection of adenocarcinoma of the colon and rectum Cancer 45 2969 2974
20. SJ Pilipshen M Heilweil SH Quan SS Sternberg WW Enker 1984 Patterns of pelvic recurrence following definitive resections of rectal cancer Cancer 53 1354 1362
21. E Grabbe R Winkler 1985 Local recurrence after sphincter saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods Radiology 155 305 310
22. YM Chen DJ Ott NT Wollfman DW Gelfand N Karsteadt RE Bechtold 1987 Recurrent colorectal carcinoma: evaluation with barium enema examination and CT Radiology 163 307 310
23. CG Moertel TR Fleming JS Macdonald DG Haller JA Laurie G Tangen 1993 An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 270 943 947
24. G Beets F Penninckx C Schiepers 1994 Clinical value of whole body positron emission tomography with [18F] fluorodeoxyglucose in recurrent colorectal cancer Br J Surg 81 1666 1670
25. J Ruhlman A Schomburg H Bender 1997 Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patient studied in routine daily practice Dis Colon Rectum 40 1195 1204
26. D Delbeke JV Vitola MP Sandler 1997 Staging recurrent metastatic colorectal carcinoma with PET J Nucl Med 38 1196 1201
27. FL Flanagan F Dehdashti OA Ogunbiyi IJ Kodner BA Siegel 1998 Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer Ann Surg 227 319 323
28. PE Valk E Abella-Columna MK Hasemen 1999 Whole-body PET imaging with [18F] fluorodeoxyglucose in management of recurrent colorectal cancer Arch Surg 134 503 511
29. Y Fong PF Saldinger T Akhurst 1999 Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases Am J Surg 178 282 287
30. L Staib H Schirrmeister SN Reske HG Beger 2000 Is (18)F- fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 180 1 5
31. MH Whiteford HM Whiteford LF Yee 2000 Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum Dis Colon Rectum 43 759 767
32. T Arulampalam D Costa D Visvikis P Boulos I Taylor P Ell 2001 The impact of FDG-PET on the management algorithm for recurrent colorectal cancer Eur J Nucl Med 28 1758 1765
33. GU Hung YC Shiu SC Tsai TH Chao YJ Ho CH Kao 2001 Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer Anticancer Res 21 1375 1378
34. M Lonneux AM Reffad R Detry A Kartheuser JF Gigot S Pauwels 2002 FDG-PET improves the staging and selection of patients with recurrent colorectal cancer Eur J Nucl Med Mol Imaging 29 915 921
35. C Schiepers F Penninckx N De Vadder 1995 Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging Eur J Surg Oncol 21 517 522
36. MT Keogan VJ Lowe ME Baker VG [tmp] McDermott HK Lyerly RE Coleman 1997 Local recurrence of rectal cancer: evaluation of F-18 fluorodeoxyglucose PET imaging Abdom Imaging 22 332 337
37. OA Ogunbiyi FL Flanagan F Dehdashti 1997 Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography Ann Surg Oncol 4 613 620
38. P Flamen S Stroobants E Van Cutsem 1999 Additional value of whole body positron emission tomography with fluorine-18-2-flouro-2-deoxy-D-glucose in recurrent colorectal cancer J Clin Oncol 17 894 901
39. KM Boyle PM Sagar AG Chalmers 2005 Surgery for locally recurrent cancer Dis Colon Rectum 48 929 937
40. E Even-Sapir Y Parag H Lerman 2004 Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection Radiology 232 815 822
41. RH Huebner KC Park JE Shepherd 2000 A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 1177 1189
42. RH Reznak FE White JW Young IK Fry RJ Nicholls 1983 The appearance on computed tomography after abdominoperineal resection for carcinoma of the rectum: a comparison between the normal appearances and those of recurrences Br J Radiol 56 237 240
43. AA Moss 1989 Imaging of colorectal carcinoma Radiology 170 308 310
44. FM Kelvin M Korobkin DK Heaston JP Grant O Akwari 1983 The pelvis after surgery for rectal carcinoma: serial CT serial observations with emphasis on nonneoplastic features AJR Am J Roentgenol 141 959 964
45. GP Krestin W Steinbrich G Friedmann 1988 Recurrent rectal cancer: diagnosis with MR imaging versus CT Radiology 168 307 311
46. JS Gomberg AC Friedman PD Radecki K Grumback DF Caroline 1986 MRI differentiation of recurrent colorectal carcinoma from post-operative fibrosis Gastrointest Radiol 11 361 363
47. F Ebner HY Kressel MC Mintz 1988 Tumor recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5T Radiology 166 333 340
48. SE Rafto MA Amendola WB Gefter 1988 MR imaging of recurrent colorectal carcinoma versus fibrosis J Comput Assist Tomogr 12 521 523
49. M Muller-Schimpfle G Brix G Layer 1993 Recurrent rectal cancer: diagnosis with dynamic MR imaging Radiology 189 881 889
50. RJ Mendez R Rodriquez T Kovacevich S Martinez G Moreno J Cerdan 1993 CT in local recurrence of rectal carcinoma J Comput Assist Tomogr 17 741 744
51. P Lind 1990 Immunoscintigraphy of colorectal carcinoma and recurrences with a technetium-99m-labeled monoclonal anti-CEA-antibody (MAB XBW 431/26) J Nucl Med 31 535 536
52. RJ Doerr H Abdel-Nabi JM Baker S Steinberg 1990 Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3 Arch Surg 125 1601 1605
53. RP Baum A Hertel M Lorenz A Schwartz A Encke G Hor 1989 99Tcm-labelled anti-CEA monoclonal antibody for tumor immunoscintigraphy: first clinical results Nucl Med Common 10 345 352
54. BD Collier Abdel-Nabi RJ Doerr 1992 Immunoscintigraphy performed with In-111-labelled CYT-103 in the management of colorectal cancer: comparison with CT Radiology 185 179 186
55. K Hughes CM Pinsky NJ Petrelli 1997 Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer Ann Surg 226 621 631
56. P Schlag B Lehner LG Strauss P Georgi C Herforth 1989 Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy Arch Surg 124 197 200
57. LG Strauss JH Clorius P Schlag 1989 Recurrence of colorectal tumors: PET evaluation Radiology 170 329 332
58. K Ito T Kato M Tadokoro 1992 Recurrent rectal cancer and scar: differentiation with PET and MR imaging Radiology 182 549 552
59. O Takeuchi N Saito K Koda H Sarashina N Nakajima 1999 Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer Br J Surg 86 932 937
60. E Even-Sapir Y Parag H Lerman 2004 Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection Radiology 232 815 822
61. T Ishimori PV Patel RL Wahl 2005 Detection of unexpected additional primary malignancies with PET/CT J Nucl Med 46 752 757
62. SM Strasberg F Dehdashti BA Siegel JA Drebin D Linehan 2001 Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study Ann Surg 233 293 299
63. JP Minton JL Hoehn DM Gerber 1985 Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study Cancer 55 1284 1290
64. JV Vitola D Delbeke MP Sandler 1996 Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver Am J Surg 171 21 26
65. DT Lai M Fulham MS Stephen 1996 The role of whole body positron emission tomography with [18F]-Fluoro-deoxyglucose in identifying operable colorectal cancer metastases to the liver Arch Surg 131 703 707
66. S Bipat M van Leeuwen E Comans 2005 Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis Radiology 237 123 131
67. TJ Babineau WD Lewis RL Jenkins R Bleday GD Steele Jr RA Forse 1994 Role of staging laparoscopy in the treatment of hepatic malignancy Am J Surg 167 151 154
68. JG Fortner JS Silva RB Golbey EB Cox BJ Maclean 1984 Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection Ann Surg 199 306 316
69. T John JD Greig JL Crosbie WF Miles OJ Garden 1994 Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound Ann Surg 220 711 719
70. M Selzner TF Hany P Wildbrett L [tmp] McCormack Z Kadry PA Clavien 2004 Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colo-rectal cancer of the liver? Ann Surg 240 1027 1034
71. B Rydzweski F Dehdashti BA Gordon SA Teeley SM Strasberg BA Siegel 2002 Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET AJR Am J Roentgenol 178 353 358
72. BS Langenhoff WJ Oyen GJ Jager 2002 Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study J Clin Oncol 20 4453 4458
73. G Savino A Di Veroncia F Martina 2004 Lung metastases from rectal adenocarcinoma: about the best diagnostic strategy Rays 29 167 174
74. JY Wang R Tang JM Chang 1994 Value of carcinoembryonic antigen in the management of colorectal cancer Dis Colon Rectum 37 272 277
75. SK Libutti HR Alexander Jr P Choyke 2001 A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labelled arcitumomab (CEA scan), and blind second look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels Ann Surg Oncol 8 779 786
76. P Rigo P Paulus BJ Kaschten 1996 Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose Eur J Nucl Med 23 1641 1644
77. V Kalff RJ Hicks RE Ware A Hogg D Binns AF Mckenzie 2002 The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study J Nucl Med 43 492 499
78. DC Desai EE Zervos MW Arnold 2003 Positron emission tomography affects surgical management in recurrent colorectal cancer patients Ann Surg Oncol 10 59 64
79. F Rosa G Meimarakis A Stahl 2004 Colorectal cancer patients before resection of hepatic metastases. Impact of (18)F-FDG PET on detecting extrahepatic disease Nuklearmedizin 43 135 140
80. J Meta M Seltzer C Schiepers 2001 Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective J Nucl Med 42 586 590
81. B Wiering PF Krabbe GJ Jager 2005 The impact of flouro-18-deoxyglucose- positron emission tomography in the management of colorectal liver metastases Cancer 104 2658 2670
82. SS Gambhir JE Shepherd BD Shah 1998 Analytical decision model for the cost-effective management of solitary pulmonary nodules J Clin Oncol 16 2113 2125
83. Australia and New Zealand Horizon Scanning Network. Combined CT and PET scanner. Horizon Scanning Report. Available at: http://www.horizonscanning.gov. au/. Accessed September 2005
84. K Imazek 1994 Study of glucose metabolism in human leucocytes using PET J Chiba Med Soc 70 169 179
85. GJ Cook MN Maisey I Fogelman 1999 Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11-methionine Eur J Nucl Med 26 1363 1378
86. VJ Lowe DM Delong JM Hoffman RE Coleman 1995 Optimum scanning protocol for FDG PET evaluation of pulmonary malignancy J Nucl Med 36 883 887
87. P Bourguet MP Blanc-Vincent A Boneu L Bosquet B Chauffert C Corone 2003 Summary of the standards, options and recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDG-PET scanning) in oncology (2002) Br J Cancer 89 Suppl 1 S84 S91
88. SN Reske 2001 Kotzerke. Result of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET 111 Eur J Nucl Med 28 1707 1723
89. KL Berger SA Nicholson I Dehdashti BA Siegal 2000 FDG-PET evaluation of mucinous neoplasm: correlation of FDG uptake with histopathologic features AJR Am J Roentgenol 174 1005 1008
90. Health and Technology Board for Scotland. Health Technology Assessment Advice 2; Positron emission tomography (PET) in cancer management. Available at: http://www.htbs.co.uk. Accessed September 2005
91. PM Bossuyt JG Lijmer BW Mol 2000 Randomised comparisons of medical tests: sometimes invalid, not always efficient Lancet 356 1884 1887
92. KA Miles 2001 An approach to demonstrating cost effectiveness of diagnostic imaging modalities in Australia illustrated by positron emission tomography Australas Radiol 45 9 18
93. KC Park J Schwimmer JE Shepherd 2001 Decision analysis for the cost-effective management of recurrent colorectal cancer Ann Surg 233 310 319
94. PE Valk TR Pounds RD Tesar 1996 Cost-effectiveness of PET imaging in clinical oncology Nucl Med Biol 23 737 743
95. SS Gambhir CK Hoh ME Phelps I Madar J Maddah 1996 Decision tree sensitivity analysis for cost effectiveness of FDG-PET in the staging and management of non-small lung carcinoma J Nucl Med 37 1428 1436
96. PM Sagar JH Pemberton 1996 Surgical management of locally recurrent rectal cancer Br J Surg 83 293 304
97. SM Larson AM Cohen MB Cascade 1994 Clinical application and economic implication of PET in the assessment of colorectal cancer recurrence: a retrospective study. 1994 ICP Meeting Institute for Clinical PET Fairfax, Virginia
98. C Lejeunne MJ Bismuth T Conroy 2005 Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer J Nucl Med 46 2020 2028
99. JM Zubeldia EM Bednarczyk JG Baker HA Nagi 2005 The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases Cancer Biother Radiopharm 20 450 456